Detailed information for compound 1281584
Basic information
Technical information
- TDR Targets ID: 1281584
- Name: N-(1,5-dimethyl-3-oxo-2-phenylpyrazol-4-yl)-6 -(1,3-dioxoisoindol-2-yl)hexanamide
- MW: 446.498 | Formula: C25H26N4O4
-
H donors: 1
H acceptors: 4
LogP: 3.05
Rotable bonds: 9
Rule of 5 violations (Lipinski): 1 - SMILES: O=C(Nc1c(C)n(n(c1=O)c1ccccc1)C)CCCCCN1C(=O)c2c(C1=O)cccc2
- InChi: 1S/C25H26N4O4/c1-17-22(25(33)29(27(17)2)18-11-5-3-6-12-18)26-21(30)15-7-4-10-16-28-23(31)19-13-8-9-14-20(19)24(28)32/h3,5-6,8-9,11-14H,4,7,10,15-16H2,1-2H3,(H,26,30)
- InChiKey: SNZRZRBNTFIVQL-UHFFFAOYSA-N
Network
Hover on a compound node to display the structore
Synonyms
- N-(1,5-dimethyl-3-oxo-2-phenyl-pyrazol-4-yl)-6-(1,3-dioxoisoindolin-2-yl)hexanamide
- N-(1,5-dimethyl-3-oxo-2-phenyl-4-pyrazolyl)-6-(1,3-dioxo-2-isoindolinyl)hexanamide
- 6-(1,3-diketoisoindolin-2-yl)-N-(3-keto-1,5-dimethyl-2-phenyl-pyrazol-4-yl)hexanamide
- N-(1,5-dimethyl-3-oxo-2-phenyl-pyrazol-4-yl)-6-(1,3-dioxoisoindol-2-yl)hexanamide
- ZINC02680404
- A1715/0073132
- EU-0018263
- MLS000698275
- N-(1,5-dimethyl-3-oxo-2-phenyl-2,3-dihydro-1H-pyrazol-4-yl)-6-(1,3-dioxo-1,3-dihydro-2H-isoindol-2-yl)hexanamide
- SMR000225552
Targets
Known targets for this compound
| Species | Target name | Source | Bibliographic reference |
|---|---|---|---|
| Homo sapiens | _UBC13, UbcH-ben, UbcH13 | Starlite/ChEMBL | No references |
| Homo sapiens | lamin A/C | Starlite/ChEMBL | No references |
Predicted pathogen targets for this compound
By orthology
By sequence similarity to non orthologous known druggable targets
| Species | Potential target | Known druggable target | Length | Alignment span | Identity |
|---|---|---|---|---|---|
| Plasmodium falciparum | ubiquitin-conjugating enzyme E2, putative | _UBC13, UbcH-ben, UbcH13 | 152 aa | 153 aa | 32.0 % |
Obtained from network model
Ranking Plot
Putative Targets List
| Species | Potential target | Raw | Global | Species |
|---|---|---|---|---|
| Echinococcus granulosus | intermediate filament protein | 0.0033 | 0.5552 | 0.5552 |
| Entamoeba histolytica | ubiquitin-conjugating enzyme family protein | 0.0046 | 1 | 0.5 |
| Onchocerca volvulus | 0.0033 | 0.5552 | 0.5 | |
| Echinococcus granulosus | ubiquitin conjugating enzyme E2 N | 0.0046 | 1 | 1 |
| Echinococcus granulosus | lamin dm0 | 0.0033 | 0.5552 | 0.5552 |
| Loa Loa (eye worm) | intermediate filament protein | 0.0033 | 0.5552 | 0.5552 |
| Loa Loa (eye worm) | ubiquitin conjugating enzyme protein 13 | 0.0046 | 1 | 1 |
| Brugia malayi | Intermediate filament tail domain containing protein | 0.0033 | 0.5552 | 0.5283 |
| Loa Loa (eye worm) | hypothetical protein | 0.0033 | 0.5552 | 0.5552 |
| Echinococcus granulosus | lamin | 0.0033 | 0.5552 | 0.5552 |
| Trypanosoma cruzi | ubiquitin-conjugating enzyme E2, putative | 0.0046 | 1 | 0.5 |
| Leishmania major | ubiquitin-conjugating enzyme e2, putative | 0.0046 | 1 | 0.5 |
| Onchocerca volvulus | 0.0033 | 0.5552 | 0.5 | |
| Echinococcus multilocularis | musashi | 0.0033 | 0.5552 | 0.5552 |
| Plasmodium vivax | ubiquitin-conjugating enzyme E2 N, putative | 0.0046 | 1 | 0.5 |
| Echinococcus multilocularis | lamin | 0.0033 | 0.5552 | 0.5552 |
| Schistosoma mansoni | ubiquitin conjugating enzyme 13 | 0.0046 | 1 | 1 |
| Trypanosoma cruzi | ubiquitin-conjugating enzyme E2, putative | 0.0046 | 1 | 0.5 |
| Loa Loa (eye worm) | hypothetical protein | 0.0032 | 0.5355 | 0.5355 |
| Plasmodium falciparum | ubiquitin-conjugating enzyme E2 N, putative | 0.0046 | 1 | 0.5 |
| Loa Loa (eye worm) | cytoplasmic intermediate filament protein | 0.0017 | 0.057 | 0.057 |
| Trichomonas vaginalis | ubiquitin-conjugating enzyme E2, putative | 0.0046 | 1 | 0.5 |
| Trypanosoma brucei | ubiquitin-protein ligase, putative | 0.0046 | 1 | 0.5 |
| Loa Loa (eye worm) | ubiquitin conjugating enzyme protein 13 | 0.0046 | 1 | 1 |
| Brugia malayi | ubiquitin conjugating enzyme protein 13 | 0.0046 | 1 | 1 |
| Brugia malayi | intermediate filament protein | 0.0033 | 0.5552 | 0.5283 |
| Toxoplasma gondii | ubiquitin-conjugating enzyme subfamily protein | 0.0046 | 1 | 0.5 |
| Loa Loa (eye worm) | intermediate filament tail domain-containing protein | 0.0033 | 0.5552 | 0.5552 |
| Echinococcus multilocularis | lamin dm0 | 0.0033 | 0.5552 | 0.5552 |
| Echinococcus multilocularis | ubiquitin conjugating enzyme E2 N | 0.0046 | 1 | 1 |
| Trichomonas vaginalis | ubiquitin-conjugating enzyme E2, putative | 0.0046 | 1 | 0.5 |
Activities
| Activity type | Activity value | Assay description | Source | Reference |
|---|---|---|---|---|
| IC50 (functional) | = 0.709 uM | PUBCHEM_BIOASSAY: Dose Response confirmation of uHTS for the identification of UBC13 Polyubiquitin Inhibitors via a TR-FRET Assay reconfirm. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID485273, AID485343, AID493155] | ChEMBL. | No reference |
| IC50 (functional) | = 1.228 uM | PUBCHEM_BIOASSAY: Dose Response confirmation of uHTS for the identification of UBC13 Polyubiquitin Inhibitors via a TR-FRET Assay. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID485273, AID485343, AID493182] | ChEMBL. | No reference |
| IC50 (functional) | > 20 uM | PUBCHEM_BIOASSAY: Dose Response confirmation of UBC13 Polyubiquitin Inhibitors using a Bfl-1 counterscreen. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID485273, AID485343] | ChEMBL. | No reference |
| Potency (functional) | = 1.4125 um | PUBCHEM_BIOASSAY: qHTS Assay for Modulators of Lamin A Splicing. (Class of assay: confirmatory) | ChEMBL. | No reference |
| Potency (functional) | 89.1251 uM | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Histone Lysine Methyltransferase G9a. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504404] | ChEMBL. | No reference |
Phenotypes
Whole-cell/tissue/organism interactions
We have no records of whole-cell/tissue assays done with this compound
What does this mean?
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
Annotated phenotypes:
We have no manually annotated phenotypes for this drug.
What does this mean? / Care to help?
In TDR Targets, information about phenotypes that are caused by
drugs, or by genetic manipulation of cells (e.g. gene knockouts or
knockdowns) is manually curated from the literature. These
descriptions help to describe the potential of the target for drug
development. If no information is available for this gene or if the
information is incomplete, this may mean that i) the papers
containing this information either appeared after the curation
effort for this organism was carried out or they were inadvertently
missed by curators; or that ii) the curation effort for this
organism has not yet started.
In any case, if you have information about papers containing relevant validation data for this target, please log in using your TDR Targets username and password and send them to us using the corresponding form in this page (only visible to registered users) or contact us.
In any case, if you have information about papers containing relevant validation data for this target, please log in using your TDR Targets username and password and send them to us using the corresponding form in this page (only visible to registered users) or contact us.
External resources for this compound
- ChEMBL: CHEMBL1381940
Bibliographic References
No literature references available for this target.
If you have references for this compound, please enter them in a user comment (below) or Contact us.